Literature DB >> 3053931

Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18-24 months of age.

H Käyhty1, O Mäkelä, J Eskola, L Saarinen, I Seppälä.   

Abstract

The serum antibody response to Haemophilus influenzae type b capsular polysaccharide or its protein conjugate vaccine (PRP and PRP-D, respectively) was studied in 28 children initially immunized at the age of 24 mo with either vaccine and in 10 children immunized for the third time with PRP-D at the age of 18 mo. The methods used were isotype-resolving enzyme immunoassay, Farr-type radioimmunoassay, and the in vitro bactericidal activity (BCA) test. Immunization with PRP evoked a higher proportion of IgA antibodies than did either the first or third dose of PRP-D, whereas the latter vaccine evoked a somewhat higher IgG response, but the differences were not statistically significant. In all groups the IgG antibody responses were predominantly IgG1, with the mean proportions being 82.2%, 84.2%, and 65.9% in the PRP, first-dose PRP-D, and third-dose PRP-D groups, respectively. Postimmunization antibodies were functionally active in the BCA test.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053931     DOI: 10.1093/infdis/158.5.973

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F, and 23F in pneumococcal reference serum 89-SF.

Authors:  A Soininen; I Seppälä; T Wuorimaa; H Käyhty
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

Review 2.  Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations.

Authors:  E E Adderson
Journal:  Springer Semin Immunopathol       Date:  2001-12

3.  Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay.

Authors:  D V Madore; P Anderson; B D Baxter; G M Carlone; K M Edwards; R G Hamilton; P Holder; H Käyhty; D C Phipps; C C Peeters; R Schneerson; G R Siber; J I Ward; C E Frasch
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

4.  Immunological properties of recombinant porin of Haemophilus influenzae type b expressed in Bacillus subtilis.

Authors:  R Srikumar; D Dahan; M F Gras; L Saarinen; H Käyhty; M Sarvas; L Vogel; J W Coulton
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.

Authors:  M T Jelonek; S J Chang; C Y Chiu; M K Park; M H Nahm; J I Ward
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.

Authors:  L L Gheesling; G M Carlone; L B Pais; P F Holder; S E Maslanka; B D Plikaytis; M Achtman; P Densen; C E Frasch; H Käyhty
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

7.  Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21.

Authors:  Amritha Ramakrishnan; Nina M Schumack; Christina L Gariepy; Heather Eggleston; Gladys Nunez; Nereyda Espinoza; Monica Nieto; Rosa Castillo; Jesus Rojas; Andrea J McCoy; Zoltan Beck; Gary R Matyas; Carl R Alving; Patricia Guerry; Frédéric Poly; Renee M Laird
Journal:  mSphere       Date:  2019-05-01       Impact factor: 4.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.